July 11, 2022

Perseus Proteomics Inc.

Securities Code: 4882 Growth TSE

To all stakeholders,

Notice on Determination of Stock Option (Share acquisition rights) Details

Perseus Proteomics Inc. (The Company) announces that today the details are determined as follows regarding share acquisition rights as stock option to the board members, executive directors, and employees according to its Board of Directors resolution on June 23, 2022.

1. Persons to be allotted share acquisition rights and number of share acquisition rights

5 Board member excluding directors, auditors and supervisory committee members

2,200 rights

3

Directors, auditors and supervisory committee members

120 rights

1

Executive director

240 rights

21 Employees

1,130 rights

  1. Number of share acquisition rights 3,690
  2. Class and number of shares to be issued as share acquisition rights

Common stock of the Company

369,000 shares

4. Value of property to be contributed at the exercise of share acquisition rights 42,400 yen per share acquisition right (424 yen per share)

[reference]

Date of the Board of Directors resolution:

June 23, 2022

END

1 / 1

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Perseus Proteomics Inc. published this content on 11 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 July 2022 08:43:01 UTC.